Putri, Devi Andiani, et al. “Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-Mutation Colorectal Cancer”. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), vol. 22, no. 1, Aug. 2025, pp. 6-11, doi:10.30595/pharmacy.v22i1.24298.